Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chatenoud

Showing results (11-20 of 259) with videos related to

Pageof 26
Sort By:
Transplantation Proceedings|October 1, 1988
Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effectsL Chatenoud
Handbook of Experimental Pharmacology|December 12, 2007
The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinicL Chatenoud
La Revue Du Praticien|December 1, 1988
[Diagnostic and therapeutic use of monoclonal anti-T lymphocyte antibodies]L Chatenoud
Current Opinion in Immunology|December 1, 1989
Monoclonal antibodiesL Chatenoud
Molecular Medicine Today|March 12, 1998
Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunityL Chatenoud
Annales De Dermatologie Et De Venereologie|June 28, 2006
[Psoriasis and cancer: more than a chance link]L Naldi, L Chatenoud
Kidney International|March 1, 1984
T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritisE Rothschild, L Chatenoud
Nephrologie|January 1, 1987
[In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts]L Chatenoud, J F Bach
Kidney International|August 1, 1981
Abnormalities of T-cell subsets in glomerulonephritis and systemic lupus erythematosusL Chatenoud, M A Bach
Chemical Immunology|January 1, 1995
Immunosuppression in insulin-dependent diabetes mellitus: from cellular selectivity towards autoantigen specificityJ F Bach, L Chatenoud
Pageof 26

Showing results (11-20 of 259) with videos related to

Sort By:
Pageof 26
Transplantation Proceedings|October 1, 1988
Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effectsL Chatenoud
Handbook of Experimental Pharmacology|December 12, 2007
The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinicL Chatenoud
La Revue Du Praticien|December 1, 1988
[Diagnostic and therapeutic use of monoclonal anti-T lymphocyte antibodies]L Chatenoud
Current Opinion in Immunology|December 1, 1989
Monoclonal antibodiesL Chatenoud
Molecular Medicine Today|March 12, 1998
Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunityL Chatenoud
Annales De Dermatologie Et De Venereologie|June 28, 2006
[Psoriasis and cancer: more than a chance link]L Naldi, L Chatenoud
Kidney International|March 1, 1984
T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritisE Rothschild, L Chatenoud
Nephrologie|January 1, 1987
[In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts]L Chatenoud, J F Bach
Kidney International|August 1, 1981
Abnormalities of T-cell subsets in glomerulonephritis and systemic lupus erythematosusL Chatenoud, M A Bach
Chemical Immunology|January 1, 1995
Immunosuppression in insulin-dependent diabetes mellitus: from cellular selectivity towards autoantigen specificityJ F Bach, L Chatenoud
Pageof 26